Al Noman Abdullah, Alhudhaibi Abdulrahman Mohammed, Afroza Moushumi, Tonni Susmita Deb, Shehab Habibul Mohsin, Jahan Iba Nusrat, Taha Tarek H, Abdallah Emad M
School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh, Saudi Arabia.
Front Microbiol. 2025 Aug 20;16:1629349. doi: 10.3389/fmicb.2025.1629349. eCollection 2025.
Neuroplasticity, the brain's ability to reorganize and adapt, has traditionally been attributed to external stimuli, learning, and experience. However, emerging research highlights the gut microbiota as a key modulator of neuroplasticity through the gut-brain axis. This review examines the mechanisms by which intestinal microorganisms influence brain function, including microbial metabolite production, immune system modulation, neurotransmitter synthesis, and hormonal regulation. Dysbiosis, or microbial imbalance, has been linked to neurodevelopmental disorders, major depressive disorder (MDD), and cognitive impairments, emphasizing the microbiome's role in psychiatric and neurological health. Animal and human studies suggest that microbiota-targeted interventions, such as probiotics, prebiotics, and dietary modifications, may enhance neuroplasticity and mitigate mental health disorders. Future research should focus on understanding direct microbial-neuronal interactions and developing personalized microbiome-based therapies. This study underscores the gut microbiota's potential as a novel target for improving brain plasticity and mental health outcomes.
神经可塑性,即大脑重新组织和适应的能力,传统上被认为归因于外部刺激、学习和经验。然而,新出现的研究强调肠道微生物群是通过肠-脑轴调节神经可塑性的关键因素。这篇综述探讨了肠道微生物影响大脑功能的机制,包括微生物代谢产物的产生、免疫系统调节、神经递质合成和激素调节。生态失调,即微生物失衡,与神经发育障碍、重度抑郁症(MDD)和认知障碍有关,这突出了微生物群在精神和神经健康中的作用。动物和人体研究表明,针对微生物群的干预措施,如益生菌、益生元及饮食调整,可能会增强神经可塑性并缓解精神健康障碍。未来的研究应侧重于理解微生物与神经元之间的直接相互作用,并开发基于个性化微生物群的疗法。这项研究强调了肠道微生物群作为改善大脑可塑性和心理健康结果的新靶点的潜力。